Page last updated: 2024-08-24

epigallocatechin gallate and Cardiomyopathy, Hypertrophic

epigallocatechin gallate has been researched along with Cardiomyopathy, Hypertrophic in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bayliss, CR; Dos Remedios, C; El-Mezgueldi, M; Leung, MC; Marston, SB; Messer, AE; Papadaki, M; Redwood, CS; Ward, DG	1

Other Studies

1 other study(ies) available for epigallocatechin gallate and Cardiomyopathy, Hypertrophic

Article	Year
Mutations in troponin T associated with Hypertrophic Cardiomyopathy increase Ca(2+)-sensitivity and suppress the modulation of Ca(2+)-sensitivity by troponin I phosphorylation. Archives of biochemistry and biophysics, 2016, 07-01, Volume: 601 Topics: Actin Cytoskeleton; Animals; Calcium; Cardiomyopathy, Dilated; Cardiomyopathy, Hypertrophic; Catechin; Dose-Response Relationship, Drug; Heart; Humans; Mice; Mice, Transgenic; Mutation; Myocardial Contraction; Phosphorylation; Recombinant Proteins; Troponin I; Troponin T	2016

Article

Year

Mutations in troponin T associated with Hypertrophic Cardiomyopathy increase Ca(2+)-sensitivity and suppress the modulation of Ca(2+)-sensitivity by troponin I phosphorylation.

Archives of biochemistry and biophysics, 2016, 07-01, Volume: 601

Topics: Actin Cytoskeleton; Animals; Calcium; Cardiomyopathy, Dilated; Cardiomyopathy, Hypertrophic; Catechin; Dose-Response Relationship, Drug; Heart; Humans; Mice; Mice, Transgenic; Mutation; Myocardial Contraction; Phosphorylation; Recombinant Proteins; Troponin I; Troponin T

2016